Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis

Sajad A War1, Ujendra Kumar

  • 1Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, V6T 1Z3, Canada. ujkumar@mail.ubc.ca.

Abstract

Insights

Somatostatin receptors SSTR2 and SSTR3 heterodimerize and signal via Gi-dependent pathways. This interaction inhibits cell proliferation through cytostatic and cytotoxic mechanisms, offering insights into tumor biology.

Area of Science:

  • Endocrinology
  • Molecular Cell Biology
  • Pharmacology

Background:

  • Somatostatin (SST) inhibits cell proliferation via five G protein-coupled receptors (SSTR1-5).
  • Receptor heterodimerization is critical for modulating SSTR signaling pathways.
  • This study focuses on human SSTR2/SSTR3 heterodimerization and its downstream effects.

Purpose of the Study:

  • To investigate human SSTR2/SSTR3 heterodimerization, internalization, and MAPK signaling.
  • To examine the impact of SST and specific agonists on cell proliferation and apoptosis.
  • To elucidate the signaling mechanisms of SSTR2/SSTR3 interactions.

Main Methods:

  • HEK-293 cells were cotransfected with SSTR2 and SSTR3.
  • Receptor localization, heterodimerization, and cAMP levels were assessed.
  • MAPK signaling (ERK1/2, p38), cell proliferation, and apoptosis were analyzed.

Main Results:

  • SSTR2 and SSTR3 heterodimerize at the plasma membrane and internalize upon agonist activation.
  • SST and agonists decreased cAMP levels and modulated ERK1/2 and p38 phosphorylation.
  • Gi-dependent inhibition of cell proliferation was observed, with increased PARP-1 and TUNEL staining, and induced p21/p27Kip1.

Conclusions:

  • SSTR2/SSTR3 signaling involves Gi-dependent inhibition of proliferation.
  • Mechanisms include cytostatic effects (p21/p27Kip1 induction) and cytotoxic effects (PARP-1, TUNEL).
  • Findings offer insights into SSTR-mediated signaling in tumor biology.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...